NanoVita DAO

NanoVita DAO integrates nanotechnology with health solutions, focusing on enhancing human vitality through innovative wellness products and services. NanoVita DAO is a health-focused company that specializes in applying nanotechnology to develop wellness products. The company was formed with a vision to revolutionize health solutions. It has not undergone any significant pivots or changes in operational strategy.

The company raised USD 10. 000 mn in its most recent SEED funding round on March 31, 2026, led by CGV FoF, with participation from other investors such as Candaq Fintech Group. This brings the total amount raised by the company to USD 10. 000 mn.

NanoVita specializes in the development and distribution of innovative health and wellness products designed to enhance human vitality and support overall well-being. Its core offerings include a range of nutritional supplements, advanced skincare formulations, and wellness technologies, all aimed at addressing common health concerns such as aging, energy levels, and skin health. These products leverage scientific research and proprietary formulations, catering to health-conscious consumers seeking effective solutions for improved quality of life. NanoVita products are marketed primarily in North America and select markets in Europe and Asia, targeting both individual consumers and health professionals who recommend them.

The revenue model of NanoVita is structured around direct-to-consumer sales and partnerships with health and wellness retailers. The company generates income through the sale of its flagship products, often delivered via a subscription model, ensuring customers have a continuous supply and convenience. This strategy fosters customer loyalty and stabilizes revenue streams. Pricing plans are competitive within the health and wellness market, reflecting the premium quality of the products offered.

Transactions typically occur through online platforms and select retail outlets, providing accessibility for both regular consumers and larger clients in the health and wellness sector. In March 2026, NanoVita DAO raised USD 10. 000 mn in SEED funding to build a decentralized health research ecosystem that leverages nanotechnology, artificial intelligence, real-world health data, and blockchain for open data sharing. The company plans to launch new product lines focusing on advanced health supplements and skincare solutions aimed for release by late 2027.

Additionally, it seeks to expand into new markets in Asia and Europe by 2028, utilizing its recent funding to support these initiatives.